<DOC>
	<DOCNO>NCT02108223</DOCNO>
	<brief_summary>The investigator aim evaluate patient In-vitro fertilization treatment COH ( control ovarian hyperstimulation ) cycle apply long protocol GnRH ( gonadotropin-releasing hormone ) analogue suboptimal response rFSH . The investigator evaluate compare addition rLH , increase dose rFSH control group regard result IVF patient .</brief_summary>
	<brief_title>The Evaluation Recombinant LH Supplementation Patients With Suboptimal Response Recombinant FSH Undergoing ICSI</brief_title>
	<detailed_description>1 . Aim -We aim evaluate patient In-vitro fertilization treatment COH ( control ovarian hyperstimulation ) cycle apply long protocol GnRH ( gonadotropin-releasing hormone ) analogue suboptimal response rFSH . We evaluate compare addition rLH , increase dose rFSH control group regard result IVF patient . 2 . Material Methods -Between 01.01.2009-30.04.2011 , 137 patient present infertility unit Assisted Reproduction Techniques- Department Obstetrics Gynecology- Meram Medical Faculty- Selcuk University plan ICSI-ET ( intracytoplasmic sperm injection-embryo transfer ) normal ovarian function , long protocol GnRH analogue COH ( control ovarian hyperstimulation ) rFSH include study . 52 patient consider responsive stimulation compose normal control group ( Group 1 ) . On 7th day stimulation transvaginal ultrasonography carry . Patients least 6 follicle 6-10mm follicle 10mm E2 ( Oestradiol ) level &lt; 250 pg / ml consider suboptimal response stimulation divide two group . For Group 2 ( n = 50 ) , 75IU / L rLH add treatment , Group 3 ( n = 35 ) , 75IU / L rFSH add treatment . IVF result compare group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Patients age 2339 Body mass index 18 30 kg/m2 Baseline FSH ≤12 IU/l , E2 ≤ 80 pg/ml The presence ovary uterine cavity capable sustaining pregnancy Who regular menstrual cycle ( 2135 day ) Confirmed absence pregnancy sufficient number antral follicle transvaginal US examination 3rd day menstruation Who first second IVF trial . Grade IIIIV endometriosis Clinically significant condition prevent undergoing gonadotrophin treatment More two previous assist cycle Who single ovary Unexplained gynaecological bleeding Polycystic ovary ovarian cyst unknown aetiology Previously diagnose space occupy lesion like submucous myoma , polyp , septum , synechia uterine cavity Have chromosomal anomaly .</criteria>
	<gender>Female</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>ICSI</keyword>
	<keyword>Suboptimal Ovarian Response</keyword>
	<keyword>rLH</keyword>
</DOC>